Betamethasone

倍他米松

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBetamethasone
Drug Alias NameBetametasonaBetamethasonumRinderonCelestoneSch-4831 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsUlcerative proctitisOcular inflammationParturition +[68] 
Global Approved IndicationsUlcerative proctitisInflammationHypersensitivity +[12] 
Approved Indications in ChinaInflammationHypersensitivityDermatitis +[6] 
Original Approved Country/TerritoryUnited States
Original Approved Date1961/04/17
Country/TerritoryCanadaUnited StatesTurkey +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesShionogi Pharma Co LtdIstanbul Technical University Alumni Association - Canada IncMcmaster University +[5] 
Inactive CompaniesCairo UniversityMerck & Co IncSchering Ag +[5] 
Active IndicationsUlcerative proctitisParturitionInflammation +[14] 
Inactive IndicationsOcular inflammationDrug HypersensitivityThyroiditis +[54] 

Other Information

ATC CodeA07EA04C05AA05D07AC01 +[11] 
Related LinksWikipediaDrugBankKEGG